Dentsply Sirona stock faces Q3 sales drop and revised 2026 outlook
Published on 11/10/2026 at 13:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSQ3 results reshape the outlook
- Wellspect Healthcare posted record quarterly sales with 10.1% reported growth.
- Adjusted EBITDA margin fell to 17.3%, while adjusted EPS declined year over year.
- A cumulative inventory-estimate benefit supported gross profit and is not expected to recur.
Dentsply Sirona reported third-quarter 2026 net sales of $836 million on November 5, down 7.6% from the year-earlier period. The company also updated its full-year outlook to approximately $3.5 billion in net sales and adjusted earnings per share of $1.20 to $1.30. The figures come from the company's earnings release published by Yahoo Finance.
Sales pressure remains visible
Reported gross profit reached $443 million, compared with $441 million a year earlier, and the gross margin improved to 52.9% from 48.8%. Adjusted EBITDA, however, declined to $146 million from $167 million, reducing the adjusted EBITDA margin to 17.3% from 18.4%. Adjusted EPS was $0.29, versus $0.42 in the prior-year quarter.
The company said gross profit and adjusted EBITDA included a $39 million benefit from refining its estimate for unrealized profit in inventory. The adjustment reduced the reported net loss and increased adjusted net income by approximately $30 million. Dentsply Sirona said the impact was cumulative and equivalent effects are not expected in future periods.
Wellspect offers a bright spot
Wellspect Healthcare generated record quarterly sales of $92 million, up 10.1% as reported and 11.0% in constant currency. Connected Technology Solutions revenue fell 11.0% to $230 million, while Orthodontic and Implant Solutions declined 16.6% to $171 million.
Operating cash flow was $32 million, compared with $79 million in the prior-year quarter, and free cash flow was zero versus $40 million. Dentsply Sirona repurchased 1.2 million shares for approximately $13 million during the quarter and held $195 million in cash and cash equivalents as of September 30.
Dentsply Sirona stock traded at 8.52 euros on Lang & Schwarz at 13:43 CET on Tuesday, November 10.
Dentsply Sirona stock at a glance
- Company: Dentsply Sirona Inc.
- ISIN: US24906P1093
- Nasdaq ticker: XRAY
- Lang & Schwarz quote: 8.52 euros on Tuesday, November 10, 2026 at 13:43 CET
- Third-quarter 2026 net sales: $836 million
The broader US equity market remains the relevant reference point for investors, alongside company-specific execution, through the S&P 500.
Further company news and analysis are available on More news and analyses on Dentsply Sirona stock.
